نتایج جستجو برای: tumor vaccine

تعداد نتایج: 530475  

2015
He Wang Jiyun Yu Li Li

BACKGROUND Persistent infection with high-risk human papillomavirus (HPV) is a predominant cause of cervical cancer, and HPV58 is the third most common virus detected in the patients with cervical cancer in Asia. E6 and E7 are the viral oncogenes which are constitutively expressed in HPV-associated tumor cells and can be used as target antigens for related immunotherapy. In this study, we modif...

2015
Guido Forni

Whether or not a tumor expresses peculiar antigens that differentiate it from normal cells was intensively investigated in the 1950s. A conclusive answer was provided in 1960 when George Klein showed that a tumor can be rejected by the immune response elicited by a vaccine administered to the same mouse in which the tumor was induced. Whether immunogenicity was a feature restricted only to tumo...

Journal: :Journal of immunology 1999
B K Martin J G Frelinger J P Ting

Early reports suggest that the costimulatory molecule CD86 (B7-2) has sporadic efficacy in tumor immunity, whereas changes in cancer immunity mediated by the MHC class II transactivator (CIITA) have not been extensively investigated. CIITA activates MHC class II expression in most cells; however, in the Line 1 lung carcinoma model system, CIITA activates MHC class I and well as class II. Here w...

Journal: :International journal of oncology 2015
Tsukasa Tanida Masahiro Tanemura Eiji Miyoshi Hiroaki Nagano Kenta Furukawa Yuji Nonaka Hirofumi Akita Naoki Hama Hiroshi Wada Koichi Kawamoto Shogo Kobayashi Hidetoshi Eguchi Masaki Mori Yuichiro Doki

Pancreatic cancer is a lethal disease that remains one of the most resistant to traditional therapies. Immunotherapy in pancreatic cancer induces the recruitment and activation of T cells that recognize tumor-associated antigens (TAAs); thus, the mechanism differs from that of chemotherapy and radiotherapy. The goal of cancer immunotherapy is to elicit immune responses against autologous tumors...

Journal: :Archives of otolaryngology--head & neck surgery 2010
Kibwei A McKinney Nada Al-Rawi Paulo Cesar Maciag Derek A Banyard Duane A Sewell

OBJECTIVE To develop a DNA cancer vaccine that targets the vascular endothelial growth factor receptor. DESIGN Mice were vaccinated intramuscularly with listeriolysin O-fetal liver kinase 1 (LLO-Flk1) or controls. Mice were also challenged subcutaneously with the tumor cell line TC-1. Tumor sizes were measured after vaccination. At the conclusion of the experiments, the tumors were harvested ...

Journal: :Turkish journal of medical sciences 2017
Si-Ming Wei Hang-Li Pan Li Wang Guo-Li Yin Kai Zhong Ya Zhou Shu-Jiao Yang Zhao-Liang Xin

BACKGROUND/AIM Dendritic cell-based vaccine therapy for renal cell carcinoma is effective but requires improvement. Here we explored whether combination therapy with dendritic cell-based vaccine and anti-CD69 antibody can enhance antitumor efficacy in renal cell carcinoma-bearing mice. MATERIALS AND METHODS Balb/c mice were challenged subcutaneously with murine renal cell carcinoma (Renca) ce...

2016
Markus W. Löffler P. Anoop Chandran Karoline Laske Christopher Schroeder Irina Bonzheim Mathias Walzer Franz J. Hilke Nico Trautwein Daniel J. Kowalewski Heiko Schuster Marc Günder Viviana A. Carcamo Yañez Christopher Mohr Marc Sturm Huu-Phuc Nguyen Olaf Riess Peter Bauer Sven Nahnsen Silvio Nadalin Derek Zieker Jörg Glatzle Karolin Thiel Nicole Schneiderhan-Marra Stephan Clasen Hans Bösmüller Falko Fend Oliver Kohlbacher Cécile Gouttefangeas Stefan Stevanović Alfred Königsrainer Hans-Georg Rammensee

BACKGROUND & AIMS We report a novel experimental immunotherapeutic approach in a patient with metastatic intrahepatic cholangiocarcinoma. In the 5year course of the disease, the initial tumor mass, two local recurrences and a lung metastasis were surgically removed. Lacking alternative treatment options, aiming at the induction of anti-tumor T cells responses, we initiated a personalized multi-...

Journal: :Journal of immunology 2013
Desheng Weng Baizheng Song Shigeo Koido Stuart K Calderwood Jianlin Gong

In the current study, exposure of mammary tumor cells derived from mice transgenic for the polyomavirus middle T oncogene to ionizing radiation resulted in the generation of a tumor cell population that preferentially expressed cancer stem cell markers. In addition, these cells were more resistant to subsequent radiation treatments and appeared to acquire an enhanced capacity for dissemination ...

2011
Gopal Murugaiyan Saroj Basak Bhaskar Saha Reena Agrawal Gyan C Mishra Debashis Mitra

Dendritic cells (DC) are the most potent antigens presenting cells with the capacity to stimulate naive T cells and induce primary and secondary immune responses. Due to these features DC have been exploited for vaccine delivery in an attempt to actively immunize cancer patients, but the vaccineinduced immune responses have achieved partial success but are not yet sufficient to attain robust an...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Sjoerd H van der Burg Anand G Menon Anke Redeker Marie-Claude Bonnet Jan Wouter Drijfhout Rob A E M Tollenaar Cornelis J H van de Velde Philippe Moingeon Peter J K Kuppen Rienk Offringa Cornelis J M Melief

PURPOSE The tumor-associated auto-antigen p53 is commonly overexpressed in various types of human cancer, including colorectal cancer. Experiments in preclinical models have shown that it can serve as a target for T-cell-mediated tumor-eradication. The feasibility of a p53-specific therapeutic vaccination was investigated in cancer patients. EXPERIMENTAL DESIGN A Phase I/II dose-escalation st...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید